Research ArticleArticle

Incidence of Spondyloarthropathy in Patients with Ulcerative Colitis: A Population-based Study

Raina Shivashankar, Edward V. Loftus Jr., William J. Tremaine, W. Scott Harmsen, Alan R. Zinsmeister and Eric L. Matteson
The Journal of Rheumatology July 2013, 40 (7) 1153-1157; DOI: https://doi.org/10.3899/jrheum.121029

REFERENCES

  1. 1.↵
    1. Bourikas LA,
    2. Papadakis KA
    . Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1915–24.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. D’Inca R,
    2. Podswiadek M,
    3. Ferronato A,
    4. Punzi L,
    5. Salvagnini M,
    6. Sturniolo GC
    . Articular manifestations in inflammatory bowel disease patients: a prospective study. Dig Liver Dis 2009;41:565–9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Ardizzone S,
    2. Puttini PS,
    3. Cassinotti A,
    4. Porro GB
    . Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis 2008;40 Suppl 2:S253–9.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Bernstein CN,
    2. Blanchard JF,
    3. Rawsthorne P,
    4. Yu N
    . The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001;96:1116–22.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Jose FA,
    2. Garnett EA,
    3. Vittinghoff E,
    4. Ferry GD,
    5. Winter HS,
    6. Baldassano RN,
    7. et al.
    Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:63–8.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Salvarani C,
    2. Vlachonikolis IG,
    3. van der Heijde DM,
    4. Fornaciari G,
    5. Macchioni P,
    6. Beltrami M,
    7. et al.
    Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 2001;36:1307–13.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Fornaciari G,
    2. Salvarani C,
    3. Beltrami M,
    4. Macchioni P,
    5. Stockbrugger RW,
    6. Russel MG
    . Muscoloskeletal manifestations in inflammatory bowel disease. Can J Gastroenterol 2001;15:399–403.
    OpenUrlPubMed
  8. 8.↵
    1. Orchard TR,
    2. Wordsworth BP,
    3. Jewell DP
    . Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998;42:387–91.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Salvarani C,
    2. Vlachonikolis IG,
    3. van der Heijde DM,
    4. Fornaciari G,
    5. Macchioni P,
    6. Beltrami M,
    7. et al.
    Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 2001;36:1307–13.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Palm O,
    2. Moum B,
    3. Ongre A,
    4. Gran JT
    . Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: A population study (the IBSEN study). J Rheumatol 2002;29:511–5.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. de Vlam K,
    2. Mielants H,
    3. Cuvelier C,
    4. De Keyser F,
    5. Veys EM,
    6. De Vos M
    . Spondyloarthropathy is underestimated in inflammatory bowel disease: Prevalence and HLA association. J Rheumatol 2000;27:2860–5.
    OpenUrlPubMed
  12. 12.↵
    1. Rodriguez VE,
    2. Costas PJ,
    3. Vazquez M,
    4. Alvarez G,
    5. Perez-Kraft G,
    6. Climent C,
    7. et al.
    Prevalence of spondyloarthropathy in Puerto Rican patients with inflammatory bowel disease. Ethn Dis 2008;18 Suppl 2:S2-225-9.
    OpenUrl
  13. 13.↵
    1. Lanna CC,
    2. Ferrari Mde L,
    3. Rocha SL,
    4. Nascimento E,
    5. de Carvalho MA,
    6. da Cunha AS
    . A cross-sectional study of 130 Brazilian patients with Crohn’s disease and ulcerative colitis: Analysis of articular and ophthalmologic manifestations. Clin Rheumatol 2008;27:503–9.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. St Sauver JL,
    2. Grossardt BR,
    3. Yawn BP,
    4. Melton LJ 3rd.,
    5. Rocca WA
    . Use of a medical records linkage system to enumerate a dynamic population over time: The Rochester Epidemiology Project. Am J Epidemiol 2011;173:1059–68.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Loftus EV Jr.,
    2. Silverstein MD,
    3. Sandborn WJ,
    4. Tremaine WJ,
    5. Harmsen WS,
    6. Zinsmeister AR
    . Crohn’s disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival. Gastroenterology 1998;114:1161–8.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Loftus CG,
    2. Loftus EV Jr.,
    3. Harmsen WS,
    4. Zinsmeister AR,
    5. Tremaine WJ,
    6. Melton LJ 3rd.,
    7. et al.
    Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis 2007;13:254–61.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Ingle SB,
    2. Loftus EV,
    3. Tremaine WJ,
    4. Harmsen WS,
    5. Zinsmeister AR,
    6. Melton LJ,
    7. et al.
    Increasing incidence and prevalence of inflammatory bowel disease in Olmsted County, Minnesota, 2001–2004 [abstract]. Gastroenterology 2007;132 Suppl 2:A19–20.
    OpenUrl
  18. 18.↵
    1. Dougados M,
    2. van der Linden S,
    3. Juhlin R,
    4. Huitfeldt B,
    5. Amor B,
    6. Calin A,
    7. et al.
    The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218–27.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Rudwaleit M,
    2. Landewe R,
    3. van der Heijde D,
    4. Listing J,
    5. Brandt J,
    6. Braun J,
    7. et al.
    The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770–6.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Rudwaleit M,
    2. van der Heijde D,
    3. Landewe R,
    4. Listing J,
    5. Akkoc N,
    6. Brandt J,
    7. et al.
    The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis 2009;68:777–83.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. van der Linden S,
    2. Valkenburg HA,
    3. Cats A
    . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Shivashankar R,
    2. Loftus EV,
    3. Tremaine WJ,
    4. Bongartz T,
    5. Harmsen WS,
    6. Zinsmeister AR,
    7. et al.
    Incidence of spondyloarthropathy in patients with Crohn’s disease: A population-based study. J Rheumatol 2012;39:2148–52.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Vavricka SR,
    2. Brun L,
    3. Ballabeni P,
    4. Pittet V,
    5. Prinz Vavricka BM,
    6. Zeitz J,
    7. et al.
    Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011;106:110–9.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Li WQ,
    2. Han JL,
    3. Chan AT,
    4. Qureshi AA
    . Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis 2013 March 16. [E-pub ahead of print]
  25. 25.↵
    1. Icen M,
    2. Crowson CS,
    3. McEvoy MT,
    4. Dann FJ,
    5. Gabriel SE,
    6. Maradit Kremers H
    . Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009;60:394–401.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section

Keywords

SPONDYLOARTHRITIS
ULCERATIVE COLITIS
EPIDEMIOLOGY

Keywords